制定化学性眼部毒性医疗对策时需考虑的因素。
Considerations in developing medical countermeasures against chemical ocular toxicity.
机构信息
Department of Health and Human Services, National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), 5601 Fishers Lane (1G58), Bethesda, MD, 20892, USA.
Department of Health and Human Services, National Eye Institute/National Institutes of Health (NEI/NIH), 6700B Rockledge Dr (Suite 3400), Bethesda, MD, 20817, USA.
出版信息
Toxicol Lett. 2020 Nov 1;334:1-3. doi: 10.1016/j.toxlet.2020.09.004. Epub 2020 Sep 8.
Abstract
The Chemical Countermeasures Research Program (CCRP) was established in 2006 by the National Institute of Allergy and Infectious Diseases (NIAID/NIH) on behalf of the National Institutes of Health Office of the Director (NIH OD). It is a trans-NIH initiative to expedite the discovery and early development of medical countermeasures (MCMs) that can reduce mortality and serious morbidity during and after large consequence public health emergency involving the deliberate or accidental large-scale release of highly toxic chemicals (HTCs).
摘要
化学对策研究计划（CCRP）于 2006 年由美国国立过敏和传染病研究所（NIAID/NIH）代表美国国立卫生研究院主任办公室（NIH OD）成立。它是一个跨 NIH 的倡议，旨在加快发现和早期开发医疗对策（MCMs），以减少涉及蓄意或意外大规模释放高毒性化学物质（HTCs）的大规模公共卫生紧急情况期间和之后的死亡率和严重发病率。
相似文献
1
Considerations in developing medical countermeasures against chemical ocular toxicity.制定化学性眼部毒性医疗对策时需考虑的因素。
Toxicol Lett. 2020 Nov 1;334:1-3. doi: 10.1016/j.toxlet.2020.09.004. Epub 2020 Sep 8.
2
National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019.美国国立卫生研究院（NIH）执行会议摘要：制定医疗对策以挽救阿片类药物引起的呼吸抑制（跨机构科学会议）-2019 年 8 月 6/7 日。
J Med Toxicol. 2020 Jan;16(1):87-105. doi: 10.1007/s13181-019-00750-x. Epub 2019 Dec 18.
3
The National Institutes of Health Chemical Countermeasures Research Program (NIH CCRP): A collaborative opportunity to develop effective and accessible chemical medical countermeasures for the American people.美国国立卫生研究院化学对策研究计划（NIH CCRP）：为美国民众开发有效且可及的化学医学对策的合作契机。
Drug Dev Res. 2020 Dec;81(8):907-910. doi: 10.1002/ddr.21707. Epub 2020 Jun 22.
4
Product Development within the National Institutes of Health Radiation and Nuclear Countermeasures Program.美国国立卫生研究院辐射与核对策计划内的产品研发。
Radiat Res. 2024 May 1;201(5):471-478. doi: 10.1667/RADE-23-00144.1.
5
NIAID/NIH radiation/nuclear medical countermeasures product research and development program.NIAID/NIH 辐射/核医学对策产品研究与开发计划。
Health Phys. 2010 Jun;98(6):903-5. doi: 10.1097/HP.0b013e3181bbc4df.
6
Supporting Fundamental Chemical Toxicology Research To Inform Medical Countermeasure Developments: The National Institutes of Health Chemical Countermeasures Research Program.支持基础化学毒理学研究以指导医学对策开发：美国国立卫生研究院化学对策研究计划。
Chem Res Toxicol. 2020 Apr 20;33(4):855-859. doi: 10.1021/acs.chemrestox.0c00086. Epub 2020 Mar 20.
7
NIH Policies and Regulatory Pathways to U.S. FDA licensure: Strategies to Inform Advancement of Radiation Medical Countermeasures and Biodosimetry Devices.NIH 政策和监管途径到美国 FDA 许可：辐射医学对策和生物剂量学设备推进的策略。
Radiat Res. 2022 May 1;197(5):533-553. doi: 10.1667/RADE-21-00198.1.
8
Office of the Assistant Secretary for Preparedness and Response; HHS Public Health Emergency Medical Countermeasures Enterprise implementation plan for chemical, biological, radiological and nuclear threats. Notice.应急准备与响应助理部长办公室；美国卫生与公众服务部针对化学、生物、放射和核威胁的公共卫生应急医疗对策企业实施计划。通知。
Fed Regist. 2007 Apr 23;72(77):20117-28.
9
The NIH Countermeasures Against Chemical Threats Program: overview and special challenges.美国国立卫生研究院化学威胁应对计划：概述与特殊挑战
Ann N Y Acad Sci. 2016 Jun;1374(1):5-9. doi: 10.1111/nyas.13179.
10
Recommendations on How to Manage Anticipated Communication Dilemmas Involving Medical Countermeasures in an Emergency.关于如何管理紧急情况下涉及医疗对策的预期沟通难题的建议。
Public Health Rep. 2018 Jul/Aug;133(4):366-378. doi: 10.1177/0033354918773069. Epub 2018 May 30.
引用本文的文献
1
Consilience and unity in ocular anterior segment research.眼前段研究中的整合与统一。
Int J Ophthalmol. 2024 Jul 18;17(7):1173-1183. doi: 10.18240/ijo.2024.07.01. eCollection 2024.
2
Elements of successful NIH grant applications.成功申请 NIH 资助的要素。
Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2315735121. doi: 10.1073/pnas.2315735121. Epub 2024 Apr 1.
3
Mouse Model of Nitrogen Mustard Ocular Surface Injury Characterization and Sphingolipid Signaling.氮芥眼部表面损伤的小鼠模型表征和神经酰胺信号。
Int J Mol Sci. 2024 Jan 6;25(2):742. doi: 10.3390/ijms25020742.
4
Supporting discovery and development of medical countermeasures for chemical injury to eye and skin.支持发现和开发针对眼和皮肤化学损伤的医疗对策。
Exp Eye Res. 2022 Aug;221:109156. doi: 10.1016/j.exer.2022.109156. Epub 2022 Jun 15.
5
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas.感觉神经病变和炎症对糖尿病角膜上皮伤口愈合的影响。
Prog Retin Eye Res. 2022 Jul;89:101039. doi: 10.1016/j.preteyeres.2021.101039. Epub 2022 Jan 4.
本文引用的文献
1
Ocular Surface - Merging Challenges and Opportunities.眼表——融合挑战与机遇
Transl Vis Sci Technol. 2020 Nov 2;9(12):3. doi: 10.1167/tvst.9.12.3. eCollection 2020 Nov.
2
The National Institutes of Health Chemical Countermeasures Research Program (NIH CCRP): A collaborative opportunity to develop effective and accessible chemical medical countermeasures for the American people.美国国立卫生研究院化学对策研究计划（NIH CCRP）：为美国民众开发有效且可及的化学医学对策的合作契机。
Drug Dev Res. 2020 Dec;81(8):907-910. doi: 10.1002/ddr.21707. Epub 2020 Jun 22.
3
Abstracts of Presentations from the 2020 Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat the Acute and Chronic Effects of Ocular Chemical Toxicity, 25-26 February, Bethesda, Maryland.2020年2月25日至26日于马里兰州贝塞斯达召开的跨部门科学会议：眼部化学毒性急慢性影响医学应对措施研发成果报告摘要
Toxicol Lett. 2020 May 25:1-3. doi: 10.1016/j.toxlet.2020.05.026.
4
Supporting Fundamental Chemical Toxicology Research To Inform Medical Countermeasure Developments: The National Institutes of Health Chemical Countermeasures Research Program.支持基础化学毒理学研究以指导医学对策开发：美国国立卫生研究院化学对策研究计划。
Chem Res Toxicol. 2020 Apr 20;33(4):855-859. doi: 10.1021/acs.chemrestox.0c00086. Epub 2020 Mar 20.
5
National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019.美国国立卫生研究院（NIH）执行会议摘要：制定医疗对策以挽救阿片类药物引起的呼吸抑制（跨机构科学会议）-2019 年 8 月 6/7 日。
J Med Toxicol. 2020 Jan;16(1):87-105. doi: 10.1007/s13181-019-00750-x. Epub 2019 Dec 18.
6
Preface: Discovery and development of better medical countermeasures for chemical threats targeting the nervous system.前言：针对针对神经系统的化学威胁研发更好的医学应对措施。
Neurobiol Dis. 2020 Jan;133:104557. doi: 10.1016/j.nbd.2019.104557. Epub 2019 Jul 30.
7
An Engineered Human Fibroblast Growth Factor-1 Derivative, TTHX1114, Ameliorates Short-term Corneal Nitrogen Mustard Injury in Rabbit Organ Cultures.一种工程化的人成纤维细胞生长因子-1 衍生物 TTHX1114 可改善兔器官培养中的短期角膜氮芥损伤。
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4720-4730. doi: 10.1167/iovs.18-24568.
8
Lumping and splitting.
Science. 2018 Mar 23;359(6382):1309. doi: 10.1126/science.aat5956.
9
Ocular Surface Changes After Sulfur Mustard Exposure in Rabbits, Monitored by Impression Cytology.通过印迹细胞学监测家兔暴露于芥子气后眼表的变化
Cornea. 2017 Aug;36(8):980-987. doi: 10.1097/ICO.0000000000001234.
10
Corneal toxicity induced by vesicating agents and effective treatment options.发泡剂引起的角膜毒性及有效的治疗方案。
Ann N Y Acad Sci. 2016 Jun;1374(1):193-201. doi: 10.1111/nyas.13121. Epub 2016 Jun 21.
Zotero 插件